Residency · Residency · General Surgery

Inflammatory Bowel Disease: Surgical Management

Overview

Inflammatory bowel disease encompasses two distinct entities: Crohn's disease and ulcerative colitis. Surgery plays a significant role in both conditions, with 20-30% of ulcerative colitis patients and up to 70-80% of Crohn's disease patients requiring operative intervention over their lifetime. The fundamental difference in surgical philosophy between the two diseases is critical: surgery for ulcerative colitis is curative, whereas surgery for Crohn's disease is palliative, and the goal is conservative resection to preserve bowel length.

Ulcerative Colitis

Surgical Indications

Surgical indications for ulcerative colitis span the spectrum of urgency. Emergent indications include fulminant colitis or toxic megacolon refractory to medical therapy, perforation, and massive hemorrhage. Urgent indications include medically refractory severe colitis that has failed intravenous steroids and rescue therapy. Elective indications include medically refractory disease, dysplasia or cancer, growth retardation in children, steroid dependence, and intolerable medication side effects.

Toxic Megacolon

Toxic megacolon is defined by transverse colon diameter greater than 6 cm on plain radiograph in the setting of systemic toxicity. Initial management consists of intravenous steroids, intravenous antibiotics, bowel rest, and serial abdominal examinations with imaging. If there is no response to intravenous steroids within 3-5 days, rescue medical therapy with infliximab or cyclosporine may be attempted. Surgical intervention is indicated for perforation, worsening clinical status despite medical therapy, or failure to improve within 48-72 hours of rescue therapy. The operative approach is subtotal colectomy with end ileostomy, which represents the first stage of a three-stage approach. It is essential not to perform proctectomy in the emergent setting, as this carries a high pelvic complication rate and may preclude a future ileal pouch-anal anastomosis. The rectum should be preserved for potential future reconstruction.

Elective Surgical Options

Total Proctocolectomy with Ileal Pouch-Anal Anastomosis (IPAA)

Total proctocolectomy with ileal pouch-anal anastomosis is the gold standard restorative procedure for ulcerative colitis. The entire colon and rectum are removed, an ileal J-pouch is constructed, and the pouch is anastomosed to the anal canal. The procedure can be performed in one stage without diversion in selected low-risk patients, in two stages with a diverting loop ileostomy followed by ileostomy reversal (the most common approach), or in three stages beginning with subtotal colectomy and end ileostomy, followed by completion proctectomy with IPAA and diverting ileostomy, and finally ileostomy reversal. The three-stage approach is reserved for emergent or urgent cases, malnourished patients, or immunosuppressed patients. The anastomosis may be stapled or hand-sewn: a stapled anastomosis preserves the anal transition zone with a 1-2 cm rectal cuff and generally offers better functional outcomes, whereas a hand-sewn anastomosis with mucosectomy removes all rectal mucosa and is indicated when dysplasia is present at the dentate line.

<image>Surgical diagram of the ileal pouch-anal anastomosis (J-pouch) showing the ileal reservoir configuration, stapled anastomosis to the anal canal, and diverting loop ileostomy</image>

Total Proctocolectomy with End Ileostomy

Total proctocolectomy with a permanent Brooke ileostomy is appropriate for patients who are not IPAA candidates due to poor sphincter function, low rectal cancer requiring abdominoperineal resection, or patient preference. It is a simpler operation with reliable outcomes.

Total Abdominal Colectomy with Ileorectal Anastomosis (IRA)

Total abdominal colectomy with ileorectal anastomosis is rarely performed for ulcerative colitis because the retained rectum carries ongoing disease risk and requires cancer surveillance. It occasionally has a role in elderly patients or those with indeterminate colitis.

IPAA Complications

Pouchitis is the most common long-term complication of IPAA, affecting up to 50% of patients. It is treated with metronidazole, ciprofloxacin, or a combination of both. Chronic or refractory pouchitis should raise suspicion for Crohn's disease of the pouch or autoimmune pouchitis. Anastomotic leak occurs in 5-10% of cases and is more frequent without diversion. Pouch failure requiring pouch excision and permanent ileostomy occurs in 5-10% of patients at long-term follow-up. Small bowel obstruction is the most common surgical complication, affecting 15-25% of patients. Pelvic sepsis occurs in 5-10%. An important counseling point for reproductive-age women is that IPAA is associated with a three-fold increase in female infertility due to adhesions affecting the fallopian tubes, though a laparoscopic approach may reduce adhesion formation.

Functional Outcomes of IPAA

Functional outcomes after IPAA are generally excellent. Patients typically have 4-8 bowel movements per day with 0-1 nocturnal stools. Minor incontinence occurs in 15-20% of patients, while major incontinence is rare. Quality of life is generally very good. Sexual dysfunction is uncommon but possible due to nerve injury during pelvic dissection.

Crohn's Disease

Surgical Principles

Surgery for Crohn's disease is not curative, and recurrence is the rule, occurring in up to 70% of patients at 10 years. The guiding principle is conservative resection, removing only grossly diseased bowel without the need for frozen section confirmation of margins. Preserving bowel length is paramount to preventing short bowel syndrome, and strictureplasty should be used whenever possible, particularly for jejunoileal disease. Multiple resections over time should be avoided when feasible.

Surgical Indications

The indications for surgery in Crohn's disease include medically refractory disease, stricture causing obstruction from fibrostenotic disease, fistula (including enteroenteric, enterocutaneous, enterovesical, and enterovaginal types), abscess not amenable to percutaneous drainage, perforation, hemorrhage (which is rare), dysplasia or cancer, and growth failure in children.

Ileocolic Resection

Ileocolic resection is the most common operation for Crohn's disease because the terminal ileum is the most frequently affected site. The procedure involves resection of the diseased terminal ileum and cecum with primary ileocolic anastomosis. A laparoscopic approach is preferred as it is associated with reduced adhesions and faster recovery. Regarding mesenteric division, recent evidence suggests that inclusion of the mesentery in a "mesentery-based" resection may reduce recurrence, though this is not yet standard practice. The most common anastomotic technique is a stapled side-to-side (functional end-to-end) configuration. The Kono-S anastomosis is an emerging alternative that uses an antimesenteric, hand-sewn, wide-lumen technique with potentially lower recurrence rates based on early data.

<image>Kono-S anastomotic technique showing the antimesenteric functional end-to-end hand-sewn configuration designed to create a wide lumen and reduce stricture formation at the anastomosis</image>

Strictureplasty

Strictureplasty is a bowel-preserving alternative to resection for fibrostenotic strictures. It is indicated for multiple strictures in the small bowel, patients with previous significant bowel resection, those at risk for short bowel syndrome, and fibrotic (not actively inflamed) strictures. Contraindications include actively inflamed or phlegmonous bowel, perforation, malignancy, and strictures located close to a planned resection site. | Strictureplasty Technique | Stricture Length | Configuration |

Three main techniques are used based on stricture length: the Heineke-Mikulicz technique for short strictures under 10 cm, involving a longitudinal incision with transverse closure; the Finney technique for intermediate strictures of 10-20 cm, creating a folded side-to-side configuration; and the Michelassi (isoperistaltic) technique for long strictures exceeding 20 cm, which involves a more complex side-to-side strictureplasty. The cancer risk at strictureplasty sites is very low, less than 1%, and the recurrence rate is similar to that of resection.

Perianal Crohn's Disease

Perianal disease affects 25-50% of Crohn's patients. Perianal abscesses should be drained, and a Crohn's fistula should always be ruled out. Perianal fistulae are classified according to the Parks classification into intersphincteric, transsphincteric, suprasphincteric, and extrasphincteric types. Management begins with an examination under anesthesia with seton placement for complex fistulae. Pelvic MRI is essential for anatomic delineation. Medical optimization with anti-TNF therapy, particularly infliximab, is often used in combination with surgical drainage. Definitive fistula repair is pursued only when the disease is quiescent, with options including the LIFT procedure, advancement flap, and fistula plug, all with variable success rates. Fistulotomy should be avoided for transsphincteric fistulae due to the risk of incontinence. Fecal diversion may be necessary for severe, refractory perianal disease, and proctectomy may ultimately be required if the rectum is destroyed and non-functional.

Crohn's Colitis

Segmental colectomy is appropriate for localized colonic Crohn's disease. Subtotal colectomy with ileorectal anastomosis is used for extensive colonic disease with rectal sparing. Total proctocolectomy with end ileostomy is performed for pancolitis with rectal involvement. IPAA is generally contraindicated in Crohn's disease due to a high failure rate of 30-50%, with the rare exception of Crohn's colitis without small bowel or perianal disease and after careful patient counseling.

<image>Pelvic MRI showing complex perianal Crohn's fistula with transsphincteric tract and associated intersphincteric abscess, demonstrating the relationship to the external anal sphincter</image>

Perioperative Medical Therapy Considerations

Steroids should be tapered preoperatively when possible, as they are associated with increased anastomotic complications; stress-dose steroids are administered perioperatively in patients on chronic steroid therapy. Anti-TNF agents such as infliximab and adalimumab have conflicting data regarding perioperative complications, and most centers do not delay surgery for anti-TNF washout, though some evidence suggests increased infectious complications without an increase in anastomotic leak rates. Vedolizumab may be associated with increased surgical complications in some studies. Thiopurines such as azathioprine and 6-MP may increase infectious complications but are generally continued perioperatively. Nutritional optimization with preoperative TPN or enteral supplementation is important for malnourished patients, particularly those with an albumin below 3.0 g/dL.

Postoperative Recurrence Prevention (Crohn's)

Endoscopic recurrence at the ileocolic anastomosis is extremely common, occurring in 70-90% of patients at one year as assessed by the Rutgeerts score. Colonoscopy is recommended at 6-12 months postoperatively to assess for recurrence. Risk factors for recurrence include smoking (the most important modifiable factor), penetrating disease phenotype, prior resections, and perianal disease. Medical prophylaxis options include anti-TNF therapy (the most effective), thiopurines, and mesalamine (which provides only modest benefit). Smoking cessation remains the single most important modifiable intervention to reduce recurrence.

Dysplasia and Cancer in IBD

Ulcerative colitis patients have an increased risk of colorectal cancer beginning 8-10 years after diagnosis in the setting of extensive colitis. Annual surveillance colonoscopy with chromoendoscopy is recommended. Flat (invisible) dysplasia, if confirmed by an expert pathologist, should prompt consideration of colectomy. Polypoid dysplasia that is endoscopically resectable with clear margins can be managed with continued surveillance. Crohn's disease patients face an increased risk of small bowel adenocarcinoma at stricture sites and an increased risk of colorectal cancer in the setting of Crohn's colitis.

Clinical Pearls

In emergent ulcerative colitis surgery, the surgeon should perform subtotal colectomy with end ileostomy only and should not remove the rectum or create a pouch in the acute setting. IPAA is contraindicated in Crohn's disease in most cases, and the diagnosis should always be confirmed before committing to a pouch. In Crohn's disease, bowel length should be conserved aggressively through strictureplasty and limited resections to prevent short bowel syndrome. Smoking cessation is the single most impactful intervention for reducing Crohn's recurrence after surgery. Reproductive-age women should be counseled about the fertility implications of IPAA, and a laparoscopic approach or delaying pouch creation may help mitigate this risk. A pelvic MRI should always be obtained before operating on perianal Crohn's fistulae, as unsuspected abscesses and tracts are commonly found. Preoperative nutritional optimization significantly reduces postoperative complications in malnourished IBD patients.

References

• Fazio VW, et al. Ileal pouch-anal anastomosis: Analysis of outcome and quality of life in 3707 patients. Ann Surg. 2013;257(4):679-685.
• Spinelli A, et al. ECCO guidelines on therapeutics in Crohn's disease: Surgical treatment. J Crohns Colitis. 2020;14(2):155-168.
• Lightner AL, et al. Postoperative outcomes in vedolizumab-treated patients undergoing abdominal operations for inflammatory bowel disease. J Crohns Colitis. 2018;12(2):185-190.
• Rutgeerts P, et al. Predictability of the postoperative course of Crohn's disease. Gastroenterology. 1990;99(4):956-963.
• De Cruz P, et al. Crohn's disease management after intestinal resection: A randomised trial. Lancet. 2015;385(9976):1406-1417.

Read this lecture as Markdown